OPKO Health EBITDA 2010-2024 | OPK

OPKO Health ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
OPKO Health Annual EBITDA
(Millions of US $)
2023 $-51
2022 $-116
2021 $98
2020 $144
2019 $-179
2018 $-74
2017 $-174
2016 $0
2015 $-55
2014 $-129
2013 $-63
2012 $-27
2011 $-19
2010 $-9
2009 $-22
OPKO Health Quarterly EBITDA
(Millions of US $)
2024-03-31 $-45
2023-12-31 $-43
2023-09-30 $-38
2023-06-30 $34
2023-03-31 $-4
2022-12-31 $-29
2022-09-30 $-61
2022-06-30 $18
2022-03-31 $-44
2021-12-31 $-44
2021-09-30 $57
2021-06-30 $26
2021-03-31 $59
2020-12-31 $70
2020-09-30 $43
2020-06-30 $50
2020-03-31 $-19
2019-12-31 $-89
2019-09-30 $-15
2019-06-30 $-24
2019-03-31 $-51
2018-12-31 $-66
2018-09-30 $-9
2018-06-30 $20
2018-03-31 $-18
2017-12-31 $-132
2017-09-30 $-22
2017-06-30 $-0
2017-03-31 $-19
2016-12-31 $-50
2016-09-30 $2
2016-06-30 $53
2016-03-31 $-5
2015-12-31 $14
2015-09-30 $4
2015-06-30 $-21
2015-03-31 $-53
2014-12-31 $-29
2014-09-30 $-44
2014-06-30 $-29
2014-03-31 $-27
2013-12-31 $-31
2013-09-30 $-15
2013-06-30 $-14
2013-03-31 $-3
2012-12-31 $-7
2012-09-30 $-7
2012-06-30 $-7
2012-03-31 $-7
2011-12-31 $-8
2011-09-30 $-5
2011-06-30 $-4
2011-03-31 $-3
2010-12-31 $3
2010-09-30 $-4
2010-06-30 $-5
2010-03-31 $-3
2009-12-31 $-3
2009-09-30 $-5
2009-06-30 $-5
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.871B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.815B 26.27
Intuitive Surgical (ISRG) United States $152.521B 91.88
Edwards Lifesciences (EW) United States $52.348B 34.07
DexCom (DXCM) United States $46.342B 70.20
Alcon (ALC) Switzerland $43.615B 31.25
IDEXX Laboratories (IDXX) United States $41.651B 48.82
IQVIA Holdings (IQV) United States $38.867B 22.55
STERIS (STE) Ireland $21.364B 24.96
SONOVA HOLDING (SONVY) Switzerland $18.279B 0.00
Waters (WAT) United States $17.455B 25.65
Hologic (HOLX) United States $16.670B 18.65
Fresenius Medical Care AG KGaA (FMS) Germany $11.719B 13.68
Sysmex ADR (SSMXY) Japan $10.095B 31.66
Teleflex (TFX) United States $9.692B 15.09
Globus Medical (GMED) United States $9.027B 26.46
Penumbra (PEN) United States $7.261B 82.52
Masimo (MASI) United States $7.185B 41.39
Glaukos (GKOS) United States $5.641B 0.00
TransMedics (TMDX) United States $4.713B 447.11
Integer Holdings (ITGR) United States $3.930B 23.75
PROCEPT BioRobotics (PRCT) United States $3.190B 0.00
LivaNova (LIVN) United Kingdom $2.867B 17.03
Tandem Diabetes Care (TNDM) United States $2.777B 0.00
Nihon Kohden (NHNKY) Japan $2.650B 14.04
Inari Medical (NARI) United States $2.513B 0.00
Elekta AB (EKTAY) Sweden $2.397B 18.38
Integra LifeSciences Holdings (IART) United States $2.277B 9.93
RxSight (RXST) United States $2.075B 0.00
Veracyte (VCYT) United States $1.634B 0.00
Alphatec Holdings (ATEC) United States $1.466B 0.00
Artivion (AORT) United States $0.966B 92.68
AVANOS MEDICAL, INC (AVNS) United States $0.869B 16.91
Silk Road Medical (SILK) United States $0.855B 0.00
OrthoPediatrics (KIDS) United States $0.701B 0.00
Pulse Biosciences (PLSE) United States $0.654B 0.00
IRadimed (IRMD) United States $0.545B 30.52
SiBone (SIBN) United States $0.515B 0.00
Paragon 28 (FNA) United States $0.503B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.67
ORTHOFIX MEDICAL INC (OFIX) United States $0.472B 0.00
Pacific Biosciences Of California (PACB) United States $0.455B 0.00
Treace Medical Concepts (TMCI) United States $0.377B 0.00
Nevro (NVRO) United States $0.328B 0.00
AxoGen (AXGN) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.321B 0.00
Tactile Systems Technology (TCMD) United States $0.279B 9.54
Semler Scientific (SMLR) United States $0.273B 13.85
CVRx (CVRX) United States $0.237B 0.00
AngioDynamics (ANGO) United States $0.236B 0.00
Delcath Systems (DCTH) United States $0.215B 0.00
EDAP TMS S.A (EDAP) France $0.198B 0.00
908 Devices (MASS) United States $0.196B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Accuray (ARAY) United States $0.186B 0.00
Inogen (INGN) United States $0.171B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Atossa Genetics (ATOS) United States $0.145B 0.00
Yubo Biotech (YBGJ) China $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.086B 18.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
Neuronetics (STIM) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.057B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
ReWalk Robotics (LFWD) Israel $0.038B 0.00
Lucid Diagnostics (LUCD) United States $0.037B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.022B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00